What are the fundraising trends in the regenerative agriculture market?
In our regenerative agriculture market deck, you will find everything you need to understand the market
SUMMARY
We analyzed publicly disclosed equity rounds raised by pure-play regenerative agriculture companies across 2024, full-year 2025, and January through May 2026. The dataset keeps only disclosed equity rounds of $300K or more, excludes grants, debt, project finance, acquisitions, and non-pure-play companies, and compares 2026 year-to-date activity with the same early-year window in 2025.
More capital is going into the regenerative agriculture market so far in 2026, but the increase is narrow. January through May 2026 produced about $85M across 5 deals, compared with about $57M across 8 deals over the same period in 2025.
The current market is being driven by larger rounds, not by more deals. Average round size rose from roughly $7M in early 2025 to about $17M in early 2026, while median round size increased from about $4M to about $11M.
Capital concentration is the central story in the regenerative agriculture market. Varaha alone accounts for roughly 53% of year-to-date 2026 capital, and the top 3 deals together account for about 88% of the market total.
The market is moving toward later-stage validation. Series A and Series B rounds represent about 86% of 2026 year-to-date capital, while first financings represent 0% of deals and 0% of capital in the current sample.
Soil Carbon Platforms are the strongest current subcategory. They captured about $46M, or roughly 54% of January through May 2026 capital, after having no included deals over the comparable early-2025 period.
Biological Input Platforms remain the most durable multi-year category. They led capital in 2024, were the most active category by deal count in 2025, and still produced a meaningful 2026 Series A through MYCOPHYTO.
Asia-Pacific is gaining the most capital momentum in the regenerative agriculture market. It captured about 54% of year-to-date 2026 funding, mostly because soil-carbon platforms tied to smallholder acreage and carbon-credit demand are attracting larger checks.
North America is losing visible momentum versus its early-2025 position. It had 6 of 8 deals and about 79% of early-2025 capital, but only 1 deal and about 13% of capital in January through May 2026.
The practical interpretation is selective confidence, not broad exuberance. Investors are still funding regenerative agriculture, but the largest checks are going to companies that can convert soil health, carbon removal, biodiversity, input efficiency, or farmer outcomes into measurable and monetizable value.
This chart, featured in our regenerative agriculture market deck, shows how market revenue is split across customer segments in the regenerative agriculture market
Is more or less capital going into the regenerative agriculture market?
More capital is going into the regenerative agriculture market so far in 2026, but the increase is narrower and more fragile than the headline number suggests. January through May 2026 produced about $85M across 5 deals, compared with about $57M across 8 deals over the same calendar period in 2025.
That means capital is up by roughly 51%, while deal count is down by about 38%. The direct answer is therefore: more capital is entering the regenerative agriculture market, but fewer companies are receiving it.
The most important indicator is the gap between funding volume and deal count. In early 2025, the regenerative agriculture market had 8 deals and an average round size of about $7M; so far in 2026, it has 5 deals and an average round size of about $17M.
The signal should still be read cautiously because one round dominates the current period. Varaha’s announced Series B represents about $45M, or roughly 53% of all capital raised so far in 2026.
Remove the largest deal and the market still looks modestly stronger than the comparable 2025 window, but not dramatically stronger. The honest interpretation is that the regenerative agriculture market is attracting more capital, while investors are concentrating that capital into fewer companies with clearer monetization paths.
Is regenerative agriculture funding driven by more deals or larger rounds?
Regenerative agriculture funding is currently being driven much more by larger rounds than by more deals. The regenerative agriculture market has fewer disclosed deals so far in 2026 than it had over the comparable period in 2025, but it has more capital.
That is the clearest possible sign that round size, not deal count, is carrying the current market. Average round size increased from roughly $7M to about $17M, and median round size increased from about $4M to about $11M.
Both the average and the median moved up, so the larger-round signal is not only an average distorted by one outlier. Still, the market remains highly concentrated because the top 3 deals account for about 88% of year-to-date 2026 capital.
The full-year comparison adds useful nuance. In 2025, total capital rose versus 2024 because deal count increased from 10 to 15, even though average round size fell from about $11M to about $9M and median round size fell from about $8M to about $5M.
The practical takeaway is that the funding engine changed. In 2025, the regenerative agriculture market broadened; so far in 2026, it has narrowed but deepened.
For deeper benchmarks on deal sizes, medians, and round distribution, see the full regenerative agriculture market report.
Is regenerative agriculture capital moving toward later-stage or earlier-stage companies?
Regenerative agriculture capital is moving toward later-stage companies so far in 2026. Series B alone accounts for about 53% of year-to-date 2026 capital, while Seed plus Series A account for about 34%.
The most important indicator is the disappearance of first financings. So far in 2026, none of the 5 included deals is classified as a first financing, and none of the capital went to first financings.
That is a major change from the comparable early-2025 period, when first financings represented about 38% of deals and about 23% of capital. The regenerative agriculture market is not currently rewarding brand-new company formation in the same way; it is refinancing companies that already exist.
The stage mix confirms the same point. Series A and Series B together account for about 86% of capital in January through May 2026, while Seed is only one small Prithu round at about $1M.
The right interpretation is not that early-stage regenerative agriculture has disappeared. It is that the center of capital gravity has moved toward companies that already have some proof of concept, especially in carbon revenue, biological input performance, soil intelligence, and measurable farmer outcomes.
This chart, featured in our regenerative agriculture market deck, compares the main business model options for regenerative agriculture MRV and incentives platforms
Is the regenerative agriculture market maturing or still experimental?
The regenerative agriculture market is maturing, but it is still not a fully mature venture market. It has moved beyond pure experimentation in several categories, while still lacking the density, repeat investors, late-stage depth, and megarounds normally associated with a mature market.
The strongest maturation signal is that capital is increasingly flowing to follow-on rounds. So far in 2026, all 5 included deals are follow-on financings, which means investors are backing companies that have already passed at least one external validation checkpoint.
The stage mix also points toward maturation. Varaha’s Series B, MYCOPHYTO’s Series A, and UBEES’s Series A are not tiny concept checks; they are scale-oriented rounds attached to carbon-credit origination, biological input performance, and managed regenerative pollination.
But the market remains experimental in structure. There are only 5 deals so far in 2026, no round above $50M, and no repeat investor across the included 2026 deals.
The strongest reading is that the regenerative agriculture market is graduating from experimentation to selective scale-up. The market is no longer only a collection of small pilots, but capital is still asking for proof of adoption, measurable outcomes, buyer demand, and recurring revenue.
Are new startups still entering the regenerative agriculture market?
New startups are still entering the regenerative agriculture market over the broader multi-year window, but the freshest 2026 signal says new-company formation has slowed sharply. So far in 2026, there are no first financings among the 5 included deals.
That contrasts with full-year 2025, when first financings represented 40% of deals and about 31% of capital. Soil Action, Edacious, Elaniti, Alt Carbon, Terraton, and CarbonZero.Eco all show that the 2025 market was still forming new companies across measurement, biological inputs, and soil carbon.
The tension between 2025 and early 2026 matters. A shallow reading would say startup formation stopped; a better reading is that formation was active in 2025, but the visible funding window in early 2026 has favored companies that already existed.
The regenerative agriculture market is especially vulnerable to timing distortion because deal counts are low. Five early-year deals are not enough to prove that new-company formation has structurally dried up.
The practical conclusion is that new startups are still entering the regenerative agriculture market, but early 2026 does not yet show healthy new-entry breadth. The current market looks more like a refinancing market for validated companies than a wide-open company-formation wave.
For the broader category view across first financings and startup formation, see the regenerative agriculture market deck.
Are more investors entering the regenerative agriculture market?
More credible investors are participating in the regenerative agriculture market, but more investors are not entering in a broad, systematic way. Early 2026 has about 19 unique disclosed investors across 5 deals, compared with about 21 across 8 deals over the comparable early-2025 period.
That means early 2026 has fewer named investors overall, but more investors per deal on average. The regenerative agriculture market is attracting stronger syndicates around fewer companies rather than a much larger crowd of investors.
The quality of investors matters more than the raw count. Early 2026 includes WestBridge Capital, RTP Global, Omnivore, S2G Investments, At One Ventures, Bpifrance, BNP Paribas, Innovacom, Capagro, and Starquest.
The absence of repeat investors is still important. In full-year 2025, no disclosed investor appeared in more than one included deal; so far in 2026, again, no disclosed investor appears in more than one included deal.
The best answer is that the regenerative agriculture market has better investor logos, not yet a deeper specialist investor bench. That distinction matters because a strong syndicate can validate one company, while repeat activity validates the category.
This chart, featured in our regenerative agriculture market deck, illustrates yearly funding for regenerative agriculture startups
Are top investors getting more or less active in regenerative agriculture?
Top investors are not getting more active in regenerative agriculture in a repeat-deal sense, even though higher-quality investors are appearing in individual rounds. So far in 2026, no disclosed investor appears in more than one included deal.
This is one of the most important indicators because repeat investor activity is a better sign of conviction than one-off participation. A single high-profile investor in one round validates one company; repeat participation across multiple companies validates the market.
The 2026 investor roster is still strong. WestBridge, RTP Global, Omnivore, S2G, At One Ventures, Bpifrance, BNP Paribas, Innovacom, Capagro, and Starquest are all credible names in climate, agriculture, technology, or institutional finance.
The full-year comparison reinforces the point. In 2024, S2G Ventures appeared in two deals and the Grantham Foundation family appeared in two deals; in 2025 and early 2026, no investor repeated across the included disclosed equity dataset.
The direct answer is that top investors are getting more visible, but not more active across multiple regenerative agriculture deals. The market has better logos, but it has not yet built a repeating specialist funding bench.
Which regenerative agriculture subcategories are gaining momentum?
Soil Carbon Platforms are gaining the clearest momentum in the regenerative agriculture market so far in 2026. They captured about $46M, or roughly 54% of all capital, across 2 of 5 deals.
That is a sharp change from the comparable early-2025 period, when Soil Carbon Platforms had no included deals before May. Varaha provides the large platform signal, while Prithu shows that the soil-carbon and nature-based carbon-removal model is producing more than one investable company.
Biological Input Platforms remain a major category, but their momentum is more durable than newly accelerating. They captured about $52M in 2024, about $45M in 2025, and MYCOPHYTO alone raised about $19M so far in 2026.
Farm Measurement Software is also gaining strategic momentum, even when it does not dominate dollars. The category’s capital share increased from about 6% in 2024 to 11% in 2025 and 13% so far in 2026, which suggests measurement is becoming more investable as the market shifts from narrative to proof.
The best answer is that Soil Carbon Platforms have the strongest recent momentum, Farm Measurement Software has the clearest infrastructure momentum, and Biological Input Platforms have the most durable multi-year funding base.
We cover this category shift in more detail in the market report covering regenerative agriculture subcategories.
Which regenerative agriculture subcategories are losing momentum?
Regenerative Farms and Regenerative Finance Platforms are losing momentum in the regenerative agriculture market so far in 2026. Both categories have zero included deals and zero capital in January through May 2026.
Regenerative Farms are the clearest swing category. They had no qualifying deals in 2024, surged to 3 deals and nearly $49M in 2025, and then disappeared again from the included early-2026 equity sample.
Regenerative Finance Platforms are also weak. eAgronom raised about $11M in 2024, ReSoil raised about $4M in 2025, and no included Regenerative Finance Platform deal has appeared so far in 2026.
This is important because transition finance is one of the biggest practical bottlenecks in regenerative agriculture. The fact that dedicated finance platforms are not attracting consistent equity capital suggests investors may prefer carbon platforms, software, or advisory models with clearer direct monetization.
The right interpretation is not that these subcategories are irrelevant. The market is punishing categories that look asset-heavy, service-heavy, or financing-heavy unless the company can show a clear monetization loop.
This chart, featured in our regenerative agriculture market deck, shows why Agreena is winning in regenerative agriculture
Which regions are gaining momentum in regenerative agriculture funding?
Asia-Pacific is gaining the strongest momentum in regenerative agriculture funding so far in 2026. January through May 2026 saw Asia-Pacific capture about $46M, or roughly 54% of all capital, across 2 of 5 deals.
The reason Asia-Pacific is gaining momentum is not broad deal volume alone. The reason is that the region is now associated with the largest capital pool in the market: soil-carbon and nature-based carbon-removal platforms.
Varaha and Prithu point to the same larger thesis. Smallholder-linked regenerative agriculture, biochar, agroforestry, and enhanced rock weathering can be organized into high-integrity carbon-credit supply.
Europe is also gaining momentum in a different way. Europe accounted for about 33% of early-2026 capital and 40% of early-2026 deals, a sharp rebound from its much smaller early-2025 share.
The strongest answer is that Asia-Pacific is gaining the most momentum in capital terms, while Europe is regaining momentum in deal breadth and technical-category formation. Asia-Pacific looks strongest in soil carbon; Europe looks strongest in biological inputs, pollination, and specialist infrastructure.
For ongoing regional tracking across Asia-Pacific, Europe, North America, and other regions, see the full market view on regenerative agriculture regions.
Which regions are losing momentum in regenerative agriculture funding?
North America is losing momentum in the regenerative agriculture market so far in 2026, especially relative to its very strong early-2025 position. In the comparable early-2025 window, North America captured about $45M, or 79% of capital, across 6 of 8 deals.
So far in 2026, North America has only 1 deal and about $11M, or 13% of capital. That is the clearest regional slowdown in the current dataset.
The decline is visible in both deal count and capital share. North America was the main early-2025 engine, with MyLand, Edacious, CarbonZero.Eco, Qualterra, Atlantic Sea Farms, and AdvancedAg all appearing before May.
Africa is also absent in early 2026, but that should be interpreted carefully. Africa had one included 2025 deal, Terraton, at about $12M, so the lack of early-2026 activity is not enough to prove a structural retreat.
The direct answer is that North America is losing the most visible momentum in the current period. The broader interpretation is that regional leadership is rotating: Europe led deal breadth in 2024, North America led early 2025, and Asia-Pacific leads early 2026 capital.
Is regenerative agriculture becoming more global or regionally concentrated?
The regenerative agriculture market is becoming more global over the full-year view, but the current 2026 capital picture is regionally concentrated around Asia-Pacific and Europe. Both statements are true, and the tension matters.
The full-year comparison shows globalization. In 2024, capital was split only between Europe and North America; in 2025, the market broadened to North America, Europe, Asia-Pacific, and Africa.
The early-2026 comparison is more concentrated. Asia-Pacific and Europe together account for about 87% of capital and 80% of deals, while North America is present but much smaller.
The reason this matters is that globalization can be measured by the number of regions with any activity, while concentration is measured by where the money actually goes. On the first measure, 2025 was the most global year; on the second measure, early 2026 is concentrated.
The strongest interpretation is that the regenerative agriculture market is globalizing structurally but remains regionally concentrated tactically. Regional leadership rotates quickly because the market has low deal counts and large individual rounds.
This chart, featured in our regenerative agriculture market deck, shows how soil carbon payments have driven growth in the regenerative agriculture market over time
Is regenerative agriculture capital moving toward proven winners or new opportunities?
Regenerative agriculture capital is moving toward proven winners so far in 2026, while the broader 2025 market still showed meaningful funding for new opportunities. The current-year signal is unusually clear: all included 2026 deals are follow-on financings.
The best indicator is first-financing share. In full-year 2024, first financings represented 30% of deals but only about 7% of capital; in full-year 2025, they represented 40% of deals and about 31% of capital.
So far in 2026, first financings have disappeared from the included sample. That means the current market is not broadly underwriting new regenerative agriculture startups.
The stage mix says the same thing. Series A and Series B rounds account for about 86% of capital, while Seed accounts for only one small deal and about 1% of capital.
The right answer is that the regenerative agriculture market is currently rewarding proven winners more than new opportunities. However, this should not be read as permanent closure to new startups, because full-year 2025 showed that new opportunities still attract capital.
The deeper analysis of the regenerative agriculture market tracks which companies are raising follow-on rounds and which new entrants still need to prove they can raise again.
Is the regenerative agriculture market becoming winner-takes-most?
The regenerative agriculture market is becoming more winner-skewed in the current 2026 period, but it is not yet structurally winner-takes-most over the full multi-year view. So far in 2026, the largest deal accounts for about 53% of all capital.
The top 3 deals account for about 88% of current-year capital, which is a very concentrated early-year funding structure. Over the comparable early-2025 period, the largest deal accounted for about 41% of capital and the top 3 accounted for about 73%.
However, the full-year comparison points in the opposite direction. In 2024, the top 3 deals captured about 63% of full-year capital; in 2025, the top 3 captured about 50%.
The tension is probably caused by early-year sample size and one unusually large 2026 round. Five deals are not enough to prove a permanent winner-takes-most structure, especially when one Series B drives more than half of capital.
The best interpretation is that the regenerative agriculture market is currently behaving like a selective, winner-skewed market, not yet a true winner-takes-most market. Investors are concentrating capital into companies with clearer proof, but the market has not produced one dominant company, category, or investor syndicate.
Is the next wave of regenerative agriculture winners becoming visible?
The next wave of winners in the regenerative agriculture market is becoming visible, but the signal is still early and should be treated as a shortlist rather than a confirmed outcome. The most visible emerging winners connect regenerative agriculture to measurable, monetizable outcomes.
Varaha is the clearest current winner signal because it has the largest 2026 round, a Series B stage, top-tier investors, and a business model tied to carbon-credit origination across regenerative agriculture and related carbon-removal pathways.
MYCOPHYTO is another strong signal because biological inputs have been consistently fundable across 2024, 2025, and 2026. The market repeatedly rewards companies that can improve soil biology, reduce input dependency, improve resilience, and tie those claims to agronomic performance.
Miraterra Soil is strategically important because the regenerative agriculture market is increasingly proof-dependent. Soil intelligence, MRV, nutrient-density measurement, soil chemistry, soil biology, and carbon verification are becoming core infrastructure.
UBEES is a more non-obvious contender. Regenerative pollination is not the most obvious category, but UBEES packages biodiversity, farmer programs, connected hives, agronomic support, and yield improvement into a managed service that investors can understand.
For more context on the emerging cohort of regenerative agriculture companies, see the regenerative agriculture market report.
As this chart shows, and as featured in our regenerative agriculture market deck, search interest in regenerative agriculture has been growing steadily
Is the regenerative agriculture funding landscape fragmenting or consolidating?
The regenerative agriculture funding landscape is consolidating around fewer investable themes, while the investor base itself remains fragmented. Capital is increasingly clustering around soil carbon, biological inputs, soil measurement, and measurable advisory models.
The category concentration in early 2026 is the strongest consolidation signal. Soil Carbon Platforms account for about 54% of capital, while Regenerative Farms and Regenerative Finance Platforms have no included 2026 deals so far.
The stage mix also suggests consolidation. All included 2026 deals are follow-ons, and Series A and Series B rounds dominate capital, which means investors are not spreading small checks across many new companies.
But the investor base remains fragmented. No disclosed investor appears in more than one included deal in full-year 2025 or early 2026, and the market is backed by different combinations of climate funds, ag specialists, banks, strategic investors, development-finance institutions, family offices, and impact investors.
The best answer is that the regenerative agriculture market is consolidating around proof-heavy business models while remaining fragmented in who provides the capital. That is a classic sign of a market searching for repeatable underwriting rules.
Where is investor attention shifting in regenerative agriculture?
Investor attention in the regenerative agriculture market is shifting toward measurable outcome platforms, especially soil carbon, soil intelligence, biological inputs, and regenerative models that connect directly to economic value.
The attention shift is not toward regenerative agriculture as a broad label. Investors are funding companies that can translate regenerative practice into carbon credits, soil data, input efficiency, yield resilience, biodiversity performance, pollination outcomes, or farmer revenue.
Compared with full-year 2025, the biggest shift is away from Regenerative Farms. In 2025, Regenerative Farms were the largest capital category, with about $49M and 36% of total funding; so far in 2026, they have no included deals.
Compared with 2024, investor attention has also shifted away from a Europe-heavy software and advisory mix toward a more carbon-led and Asia-Pacific-weighted market. The current market rewards companies that turn ecological change into an asset, a verified claim, a yield improvement, a farmer payment mechanism, or a commercial input advantage.
The strongest reading is that investor attention is shifting from “regenerative practices are desirable” to “regenerative outcomes must be measurable, financeable, and sellable.”
For real-time tracking of how investor attention is moving across soil carbon, biological inputs, measurement, advisory, and regional capital pools, see the full regenerative agriculture market report.
All the funding deals in the regenerative agriculture market from 2024 to Apr 2026
The table below lists every disclosed funding deal in the supplied regenerative agriculture dataset from May 2024 to April 2026, covering soil carbon platforms, biological input platforms, regenerative farms, farm measurement software, regenerative advisory services, and regenerative finance platforms.
Each row shows the company, the fundraising date, what the company does, its category, the funding stage, the round size, the region, whether it was a first financing or a follow-on, the tier-1 investor if any, and the announcement source. For the broader investability view, see our market deck.
| Company | Date | What they do | Category | Stage | Deal size | Region | First/Follow-on | Tier 1 investor(s) | Source |
|---|---|---|---|---|---|---|---|---|---|
| Prithu | Apr 2026 | Full-stack nature-based carbon-removal platform turning regenerative agriculture, agroforestry, biochar and biogas interventions into high-integrity carbon credits. | Soil Carbon Platforms | Seed | $1.2M | Asia-Pacific | Follow-on | None clearly tier-1 disclosed | Entrackr |
| Miraterra Soil | Mar 2026 | Soil intelligence and measurement technology using AI, genomics, spectroscopy, geospatial data and soil DNA data for soil biological and chemical intelligence. | Farm Measurement Software | Unknown | $11.2M | North America | Follow-on | S2G Investments; At One Ventures; Farm Credit Canada | PR Newswire |
| Varaha | Feb 2026 | Carbon-removal project developer across regenerative agriculture, biochar, afforestation, reforestation and enhanced rock weathering, with MRV and verified carbon-credit origination. | Soil Carbon Platforms | Series B | $45M | Asia-Pacific | Follow-on | WestBridge Capital; RTP Global; Omnivore | Entrackr |
| UBEES | Feb 2026 | Regenerative pollination programs using beekeeping, agronomic data, connected hives, biodiversity monitoring, field support and farmer programs. | Regenerative Advisory Services | Series A | $9.44M | Europe | Follow-on | Capagro; Starquest | Capagro |
| MYCOPHYTO | Jan 2026 | Mycorrhizal fungi biostimulants and soil-regeneration solutions that improve water retention, nutrient uptake, fertilizer efficiency, yield resilience and degraded-soil performance. | Biological Input Platforms | Series A | $18.5M | Europe | Follow-on | Bpifrance; BNP Paribas; Innovacom | MYCOPHYTO |
| ReSoil | Dec 2025 | Regenerative finance and carbon-management platform financing farmers’ agroecological transition and managing soil-carbon projects. | Regenerative Finance Platforms | Unknown | $4.4M | Europe | Follow-on | None identified | EU-Startups |
| Two Brothers Organic Farms | Oct 2025 | Regenerative and organic farming-led Indian food and farm-products company using capital for manufacturing, farmer engagement, technology and international expansion. | Regenerative Farms | Series B | $13.2M | Asia-Pacific | Follow-on | None clearly tier-1 by global VC standards; Rainmatter is a notable India impact/venture investor | Financial Express |
| NeoFarm | Sep 2025 | Designs and operates robotic agroecological farms to scale local organic and regenerative vegetable production. | Regenerative Farms | Series B | $32.4M | Europe | Follow-on | Eurazeo; Bpifrance | iGrow News |
| Good Agriculture | Sep 2025 | Back-office and AI-powered farm-management platform serving regenerative farmers with bookkeeping, taxes, financial management and funding support. | Regenerative Advisory Services | Seed | $1.5M | North America | Follow-on | Techstars | Good Agriculture |
| Terraton | Aug 2025 | Full-stack biochar platform combining software, hardware and financing to scale biochar carbon removal in emerging markets. | Biological Input Platforms | Seed | $11.5M | Africa | First financing | Lowercarbon Capital; Gigascale Capital | EZ Newswire |
| Soil Action | Aug 2025 | Real-time soil chemistry measurement platform for in-field and tractor-cab decision support. | Farm Measurement Software | Seed | $5.25M | North America | First financing | None identified | Access Newswire |
| Alt Carbon | May 2025 | Enhanced-rock-weathering platform working with farmers and scientists to turn underutilized land into carbon sinks while supporting soil restoration. | Soil Carbon Platforms | Seed | $12M | Asia-Pacific | First financing | Lachy Groom | Alt Carbon |
| AdvancedAg | Mar 2025 | Indigenous-led agricultural biotech company producing microbial soil-health and biological crop products. | Biological Input Platforms | Seed | $2M | North America | Follow-on | None identified | AdvancedAg |
| Grow Indigo | Mar 2025 | Regenerative agriculture and carbon-farming platform enrolling Indian farmers, providing advisory and MRV, and linking farmers to carbon and sustainable-produce markets. | Regenerative Advisory Services | Unknown | $10M | Asia-Pacific | Follow-on | British International Investment is a major development-finance institution, not a traditional VC tier-1 | British International Investment |
| Elaniti | Mar 2025 | Soil microbiome intelligence and digital decision-support platform using AI and DNA sequencing to improve soil health and reduce reliance on synthetic inputs. | Farm Measurement Software | Seed | $1.64M | Europe | First financing | None identified | Elaniti |
| Qualterra | Feb 2025 | Biochar and plant-diagnostics company converting crop and timber waste into carbon-trapping, crop-boosting biochar, with related plant health testing. | Biological Input Platforms | Unknown | $4.5M | North America | Follow-on | None identified | GeekWire |
| CarbonZero.Eco | Feb 2025 | Biochar-based regenerative agriculture and carbon-removal platform helping farmers increase yields while removing CO2. | Biological Input Platforms | Seed | $3.5M | North America | First financing | None disclosed as institutional tier-1 | PR Newswire |
| Edacious | Feb 2025 | Measurement platform linking soil health, farm management and nutrient-density outcomes in whole foods and ingredients. | Farm Measurement Software | Seed | $8.1M | North America | First financing | Patagonia’s Tin Shed Ventures | Edacious |
| MyLand | Jan 2025 | Soil as a Service biological soil-health platform using live native microalgae to improve soil biology, water efficiency and farm resilience. | Biological Input Platforms | Series B | $23M | North America | Follow-on | None clearly tier-1 by general VC standards; Proterra is a specialist ag/food investor | MyLand |
| Atlantic Sea Farms | Jan 2025 | Regenerative kelp farming and seaweed products, partnering with fishermen to grow domestically farmed kelp. | Regenerative Farms | Unknown | $3.8M | North America | Follow-on | None identified | NOSH |
| CroBio | Dec 2024 | Microbial soil amendment company using enhanced soil microbes to improve water retention, nutrient retention and carbon sequestration in agricultural soils. | Biological Input Platforms | Seed | $1.55M | Europe | Follow-on | Grantham Foundation for the Protection of the Environment | BioYorkshire |
| Sound Agriculture | Dec 2024 | Biological nutrient-efficiency platform using signaling chemistry and mycorrhizal fungi to reduce synthetic fertilizer needs and support healthier soils. | Biological Input Platforms | Series D+ | $25M | North America | Follow-on | BMO Impact Investment Fund; S2G Ventures; Leaps by Bayer; Syngenta Ventures | Sound Agriculture |
| Spatialise | Nov 2024 | AI and satellite-based soil-health monitoring platform measuring organic carbon and NPK nutrients in farmland topsoil. | Farm Measurement Software | Unknown | $0.38M | Europe | First financing | None identified | EU-Startups |
| Klim | Nov 2024 | Regenerative agriculture advisory, insetting and farmer-transition platform helping farmers plan, finance, execute and monetize regenerative practices. | Regenerative Advisory Services | Series A | $22M | Europe | Follow-on | BNP Paribas; Rabobank; AgFunder; Norinchukin Bank | TechCrunch |
| Soil Capital | Sep 2024 | Carbon-farming and farmer-payment platform certifying and monetizing regenerative outcomes for food companies and farmers. | Soil Carbon Platforms | Series B | $16.2M | Europe | Follow-on | Trill Impact Ventures; Santander Alternative Investments; SFPIM | Soil Capital |
| Applied Carbon | Jul 2024 | Mobile in-field biochar technology converting crop residues into biochar for soil health, agronomic productivity and carbon removal. | Biological Input Platforms | Series A | $21.5M | North America | Follow-on | Microsoft Climate Innovation Fund; S2G Ventures; Congruent Ventures; Grantham Foundation; Elemental Excelerator | PR Newswire |
| Agrobiomics | Jul 2024 | Biological crop-input company developing natural biostimulants that improve crop resilience under drought and salinity stress. | Biological Input Platforms | Seed | $4.35M | Europe | First financing | NOON Ventures | Agrobiomics |
| eAgronom | Jul 2024 | Regenerative transition and farm-finance platform combining farm software, carbon programs, sustainable loans and incentives for farmers. | Regenerative Finance Platforms | Series A | $10.8M | Europe | Follow-on | Swedbank; SmartCap Green Fund | eAgronom |
| Downforce Technologies | Jun 2024 | Soil organic carbon measurement and prediction software for farmers, landowners, corporates, carbon projects and soil-health interventions. | Farm Measurement Software | Unknown | $4.2M | Europe | Follow-on | Equator VC; CEFC/Virescent Ventures | Downforce Technologies |
| Seqana | May 2024 | Satellite and machine-learning MRV platform for measuring soil carbon and enabling scalable carbon farming projects. | Farm Measurement Software | Seed | $2.27M | Europe | First financing | HTGF | HTGF |
INSIGHTS
The insights below come from reviewing disclosed equity rounds in the regenerative agriculture market across 2024, full-year 2025, and January through May 2026.
- The regenerative agriculture market is stronger in dollars than in breadth. Capital rose from about $57M over the comparable early-2025 period to about $85M so far in 2026, but deal count fell from 8 to 5, which means current market health depends more on conviction in a few companies than on broad startup activity.
- The cleanest change from 2025 to early 2026 is the shift from formation to refinancing. Full-year 2025 had first financings at 40% of deals, while early 2026 has no first financings, so current capital is reinforcing existing companies rather than opening the market to many new entrants.
- The regenerative agriculture market increasingly prices proof over promise. Companies with carbon-credit origination, soil intelligence, biological input mechanisms, pollination performance, or farmer-payment logic raise larger rounds than companies offering general regenerative narratives.
- Soil Carbon Platforms have become the current capital magnet because they connect regenerative agriculture to an external buyer: the carbon market. That creates a clearer revenue bridge than many farm-level sustainability models can offer.
- The market’s apparent acceleration in 2026 is highly sensitive to Varaha. One announced Series B accounts for roughly 53% of current-year capital, so the headline funding number says as much about one company’s validation as it says about the entire regenerative agriculture market.
- The absence of $50M-plus equity rounds across 2024, 2025, and early 2026 is a hard ceiling signal. The regenerative agriculture market is institutionalizing, but it has not crossed into true late-stage climate-growth financing.
- Biological Input Platforms are the most durable category across the three periods. They led capital in 2024, remained the most active category by deal count in 2025, and still produced a meaningful Series A in 2026.
- Farm Measurement Software is becoming more strategically important even when it does not dominate capital. Its role is infrastructure-like: regenerative agriculture needs credible soil, carbon, nutrient, microbiome, and biodiversity proof before larger intervention or finance models can scale.
- Regenerative Farms are the most episodic category. They had no qualifying deals in 2024, became the largest capital category in 2025, and disappeared again so far in 2026, which suggests farm-asset models are lumpy and deal-specific rather than consistently venture-scalable.
- Regenerative Finance Platforms are undercapitalized relative to their importance. Transition finance is central to farmer adoption, yet the category has produced only small and inconsistent equity activity, which suggests investors may prefer carbon platforms or advisory platforms with clearer direct monetization.
- The market’s geography is rotating rather than stabilizing. Europe dominated 2024 deal breadth, North America dominated early 2025 activity, and Asia-Pacific dominates early 2026 capital because of soil-carbon platforms.
- Asia-Pacific’s rise is not just geographic diversification; it reflects a different regenerative agriculture model. The region’s strongest companies are tied to smallholder scale, nature-based carbon removal, and carbon-credit supply, not just software or inputs.
- Europe remains a formation and technical-specialist hub. European deals across the period cluster around MRV, soil carbon, biological inputs, advisory, pollination, and finance, showing a broad infrastructure role even when Europe does not lead capital.
- North America looks less dominant in 2026 because its 2025 strength was broad but not sticky. The region produced many early-2025 deals, but that activity did not carry into early 2026 at the same pace.
- The market is not winner-takes-most across years, but short windows can look that way. Full-year 2025 was less concentrated than 2024, while early 2026 is more concentrated than early 2025 because one large round dominates the period.
- Round-size distribution shows a missing growth bridge. Many companies can raise sub-$5M or $5M-to-$20M rounds, but very few cross $20M and none cross $50M, suggesting scale proof remains the main bottleneck.
- Investor quality improved faster than investor repeatability. Early 2026 includes credible names such as WestBridge, RTP Global, Omnivore, S2G, Bpifrance, BNP Paribas, and Capagro, but no investor appears in more than one included deal.
- The absence of repeat investors means the category lacks a settled underwriting consensus. A mature market would show the same specialist investors repeatedly backing adjacent models; the regenerative agriculture market still looks more opportunistic.
- The strongest business models convert regenerative agriculture from a practice into a measurable unit of value. The recurring winning pattern is carbon credits, input efficiency, yield resilience, verified soil data, biodiversity performance, or farmer income improvement.
- Measurement is becoming a gating layer for the whole market. Without reliable MRV, soil intelligence, nutrient-density data, biodiversity monitoring, or carbon accounting, the capital-intensive categories become harder to underwrite.
- The market is moving away from generic sustainability language. The companies raising meaningful capital describe specific mechanisms: mycorrhizal fungi, biochar, enhanced rock weathering, soil DNA, connected hives, regenerative pollination, nutrient efficiency, or verified carbon origination.
- The most defensible interpretation of 2026 is selective confidence, not broad exuberance. Investors are willing to fund regenerative agriculture, but only when the company has an unusually clear link between ecological improvement and revenue.
- The best forecasting rule is that future winners in the regenerative agriculture market will need to prove both agronomic credibility and commercial conversion. Ecological benefit alone will not be enough; the companies most likely to raise larger rounds will show how soil improvement, biodiversity, carbon removal, or input reduction becomes a measurable, repeatable, paid outcome.
This chart, featured in our regenerative agriculture market deck, shows how soil health monitoring technology has evolved over time
OUR METHODOLOGY TO BUILD THIS TRACKER
We built this regenerative agriculture funding tracker by reviewing publicly disclosed equity rounds raised by pure-play regenerative agriculture companies across 2024, full-year 2025, and January through May 2026. A company counts as pure-play when more than 80% of its activity is dedicated to the core regenerative agriculture scope used in this tracker.
We applied four filters to build the dataset. First, we only included equity rounds, so grants, debt, structured financings, carbon-credit pre-purchases, project finance facilities, acquisitions, SPAC transactions, and business combinations are excluded. Second, we only counted rounds of $300K or more. Third, we only kept pure-play companies in one of the covered categories: Regenerative Farms, Biological Input Platforms, Regenerative Advisory Services, Farm Measurement Software, Soil Carbon Platforms, and Regenerative Finance Platforms. Fourth, every included deal had to be confirmed by a direct company announcement, press release, tier-1 media report, specialized industry source, or relevant regional publication.
We excluded undisclosed-amount rounds because including them would distort dollar-based metrics such as total capital, average round size, category shares, regional shares, and concentration ratios. We also excluded adjacent agtech companies when regenerative agriculture was only a secondary use case, including companies primarily focused on robotics, virtual fencing, generic sustainability software, downstream food brands, or financing vehicles that were not clean equity rounds into qualifying pure-play companies.
Related blog posts
- The latest developments in regenerative agriculture
- What is the latest news in regenerative agriculture?
- How large is the regenerative agriculture market today?
- What are the latest funding developments in regenerative agriculture?
- The evolution of funding activity in regenerative agriculture
- The startups that have raised the most funding in regenerative agriculture
- The most highly valued startups in regenerative agriculture
